Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Author(s) -
Levent Sütçigil,
Çağatay Öktenli,
Uğur Muşabak,
Ali Bozkurt,
Adnan Cansever,
Özcan Uzun,
S. Yavuz Sanisoğlu,
Zeki Yeşilova,
Nahit Ozmenler,
Aytekin Özşahin,
Ali Şengül
Publication year - 2007
Publication title -
clinical and developmental immunology
Language(s) - English
Resource type - Journals
eISSN - 1740-2530
pISSN - 1740-2522
DOI - 10.1155/2007/76396
Subject(s) - proinflammatory cytokine , sertraline , cytokine , algorithm , chemokine , medicine , inflammation , mathematics , antidepressant , hippocampus
The specific associations between antidepressant treatment and alterations in the levels of cytokines remain to be elucidated. In this study, we aimed to explore the role of IL-2, IL-4, IL-12, TNF- α , TGF- β 1, and MCP-1 in major depression and to investigate the effects of sertraline therapy. Cytokine and chemokine levels were measured at the time of admission and 8 weeks after sertraline treatment. Our results suggest that the proinflammatory cytokines (IL-2, IL-12, and TNF- α ) and MCP-1 were significantly higher, whereas anti-inflammatory cytokines IL-4 and TGF- β 1 were significantly lower in patients with major depression than those of healthy controls. It seems likely that the sertraline therapy might have exerted immunomodulatory effects through a decrease in the proinflammatory cytokine IL-12 and an increase in the anti-inflammatory cytokines IL-4 and TGF- β 1. In conclusion, our results indicate that Th1-, Th2-, and Th3-type cytokines are altered in the depressed patients and some of them might have been corrected by sertraline treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom